Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing-Yu Mu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|November 29, 2021
[Subacute Thyroiditis Following HPV Vaccination: A Case Report]Qian Xie, Xing-Yu Mu, Shuang-Qing Li
BMC Medical Imaging|October 30, 2022
Establishment and evaluation of a CT-based radiomic model for AIDS-associated pulmonary cryptococcosisZi-Xin Zhang, Xing-Yu Mu, Jing Yu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 7, 2013
SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cellsMing-Yue Tan, Xing-Yu Mu, Bin Liu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|October 12, 2022
[Effect of Social Support on Multimorbidity and Related Outcomes of Middle-Aged and Older Adults in China]Xing-Yu Mu, Min-Jun Zhao, Tian-Pei Ma, et al.
Frontiers in Immunology|April 19, 2024
Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018Qing-Yue Zeng, Yu Qin, Yi Shi, et al.
Medicine|May 4, 2026
Persistent 131I uptake in the thyroglossal duct after thyroid ablation: A case report and literature reviewJie Qin, Ping Yu, Yu Long Zeng, et al.
Oncology Reports|October 2, 2018
miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10Ke Wu, Xing-Yu Mu, Jun-Tao Jiang, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2018
Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategyKe Wu, Ming-Yue Tan, Jun-Tao Jiang, et al.
Medicine|December 10, 2025
18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancerJie Qin, Zhao Ge, Yu Long Zeng, et al.
Molecular Immunology|April 6, 2019
RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatmentXing-Yu Mu, Ren-Jie Wang, Zhi-Xian Yao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|November 29, 2021
[Subacute Thyroiditis Following HPV Vaccination: A Case Report]Qian Xie, Xing-Yu Mu, Shuang-Qing Li
BMC Medical Imaging|October 30, 2022
Establishment and evaluation of a CT-based radiomic model for AIDS-associated pulmonary cryptococcosisZi-Xin Zhang, Xing-Yu Mu, Jing Yu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 7, 2013
SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cellsMing-Yue Tan, Xing-Yu Mu, Bin Liu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|October 12, 2022
[Effect of Social Support on Multimorbidity and Related Outcomes of Middle-Aged and Older Adults in China]Xing-Yu Mu, Min-Jun Zhao, Tian-Pei Ma, et al.
Frontiers in Immunology|April 19, 2024
Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018Qing-Yue Zeng, Yu Qin, Yi Shi, et al.
Medicine|May 4, 2026
Persistent 131I uptake in the thyroglossal duct after thyroid ablation: A case report and literature reviewJie Qin, Ping Yu, Yu Long Zeng, et al.
Oncology Reports|October 2, 2018
miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10Ke Wu, Xing-Yu Mu, Jun-Tao Jiang, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2018
Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategyKe Wu, Ming-Yue Tan, Jun-Tao Jiang, et al.
Medicine|December 10, 2025
18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancerJie Qin, Zhao Ge, Yu Long Zeng, et al.
Molecular Immunology|April 6, 2019
RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatmentXing-Yu Mu, Ren-Jie Wang, Zhi-Xian Yao, et al.
Pageof 2